Home > Insider Trading > Filing (0001209191-20-023954)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1708493	Harpoon Therapeutics Inc.	HARP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1683811	Natalie Sacks	C/O Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA 94080	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-04-06	700	$2.12	46,454	No	4	M	Direct
Common Stock	Disposition	2020-04-06	700	$12.00	45,754	No	4	S	Direct
Common Stock	Acquisiton	2020-04-07	570	$2.12	46,324	No	4	M	Direct
Common Stock	Disposition	2020-04-07	570	$12.00	45,754	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2020-04-06	700	$0.00	700	$2.12
Common Stock	Employee Stock Option (right to buy)	Disposition	2020-04-07	570	$0.00	570	$2.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
179,878		2028-10-17	No	4	M	Direct
179,308		2028-10-17	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Represents the weighted average sales price per share. The shares sold at prices ranging from $12.00 to $12.01 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
The stock option vested and became exercisable as to 25% of the shares subject to the option on October 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.